NEW YORK, NY / ACCESSWIRE / November 18, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viking Therapeutics, Inc. ("Viking Therapeutics, Inc.") (NASDAQ:VKTX) ...
Revenue for the third quarter of 2024 (“Q3 2024”) was $521,316, compared to $148,965 in the third quarter of 2023 (“Q3 2023”), which equates 250% growth ...
Vancouver, BC – TheNewswire - November 18, 2024 – Muzhu Mining Ltd. (CSE:MUZU) (“Muzhu” or the “Company”) is pleased to announce that the Company has ...
SAN FRANCISCO, Nov. 18, 2024 /PRNewswire/ -- General Motors made history recently, driving all 20 of our Super Cruise-enabled ...
Global gaming and entertainment company MGM Resorts International signs a Whole Portfolio Agreement with Cisco to deliver ...
or contact Joseph E. Levi, Esq. via email at
[email protected] or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit ...
or contact Joseph E. Levi, Esq. via email at
[email protected] or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit ...
NAPERVILLE, Ill., Nov. 18, 2024 /PRNewswire/ -- Chicago Rivet & Machine Co. (NYSE American: CVR) today announced that its Board of Directors declared a quarterly cash dividend of $0.03 per share ...
Reflecting as reported performance from continuing operations, fourth quarter revenue increased 7% to $4.1 billion, operating ...
Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence ...
Lung12, patients will be screened with the GRAIL assay prior to surgery to inform eligibility for post-surgery randomization to an adjuvant treatment regimen ( NCT06564844 ). Assay performance was ...
New York, New York--(Newsfile Corp. - November 18, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE ...